New York Blood Center Enterprises Grants Exclusive License to Big Eye Diagnostics for Diagnostic Biomarkers in River Blindness
Global health partners join forces to manufacture and commercialize a new rapid diagnostic test in support of WHO’s onchocerciasis control and elimination program
